RecruitingPhase 2 / Phase 3NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Sponsor: BioNTech SE
Birmingham, AL · +52 more sites
Lung Cancer clinical trials in Birmingham, AL
16 recruiting lung cancer studies with a site in Birmingham, AL.
RecruitingPhase 3NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Sponsor: Pfizer
Alabaster, AL · Bessemer, AL · Birmingham, AL · +238 more sites
RecruitingPhase 2NCT05967689
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Sponsor: Taiho Oncology, Inc.
Birmingham, AL · +17 more sites
RecruitingPhase 3NCT06216301
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Sponsor: NovoCure GmbH
Birmingham, AL · +37 more sites
RecruitingPhase 1 / Phase 2NCT06362252
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Sponsor: Daiichi Sankyo
Birmingham, AL · +25 more sites
RecruitingPhase not listedNCT07124000
DESTINY-PANTUMOUR04
Sponsor: AstraZeneca
Birmingham, AL · +17 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Birmingham, AL · +17 more sites
RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Birmingham, AL · +31 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Birmingham, AL · +32 more sites
RecruitingPhase 2NCT07098988
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
Sponsor: CatalYm GmbH
Birmingham, AL · +6 more sites
RecruitingPhase 1NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Sponsor: Novartis Pharmaceuticals
Birmingham, AL · +8 more sites
RecruitingPhase 2NCT06364917
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase not listedNCT05915208
Histiocytic Disorder Follow-up Study
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 2 / Phase 3NCT03851445
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
Birmingham, AL · Daphne, AL · Fairhope, AL · +1226 more sites
RecruitingPhase 2NCT06841055
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
Sponsor: BioNTech SE
Birmingham, AL · +4 more sites
RecruitingPhase not listedNCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study
Sponsor: Tempus AI
Birmingham, AL · +57 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.